6 completed, 2 active not recruiting, 2 terminated, 1 unknown. 3 Phase 2, 3 Phase 3, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Active not recruiting 1 |
| Phase 3 | 3 | Completed 2, Terminated 1 |
| Not applicable | 2 | Completed 2 |
Follow Institut Pasteur de Dakar: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Maternal Probiotic Intervention to Improve Gut Health-Trial II-Pakistan Oral Vancomycin, VE818, Placebo - Environmental Enteric Dysfunction (EED), Stunting | Phase 2 | Active not recruiting | Aga Khan University | 144 | 2025-08-30 | 2026-11-05 |
| Clinical Diagnostic Performance Evaluation of a Measles Rapid Test in Senegal Measles rapid diagnostic test - Measles | Terminated | Institut Pasteur de Dakar | 254 | 2025-08-22 | 2026-09-02 | |
| African Studies on Aging and Noncommunicable Diseases Epidemiology Cardio Vascular Disease, Cardiovascular | Active not recruiting | Alliance For Medical Research in Africa | 1000000 | 2025-01-15 | 2026-02-23 | |
| Probiotic For the Improvement of Environmental Enteropathy in Pregnant Women in Senegal Probiotic, Placebo, CapScanĀ® - Environmental Enteric Dysfunction | Phase 2 | Completed | Institut Pasteur de Dakar | 76 | 2024-06-06 | 2026-06-26 |
| Performance of the Echopen Probe in Its Clinical Use for Pregnancy Follow-up in Senegal echOpen O1 Handheld Ultrasound device - Pregnancy Related | Not applicable | Completed | echOpen Factory | 224 | 2023-11-29 | 2025-09-19 |
| Maternal Probiotic Intervention to Improve Gut Health Vivomixx, CapScanĀ® - Environmental Enteric Dysfunction, Stunting | Phase 2 | Completed | Aga Khan University | 76 | 2023-08-09 | 2025-07-16 |
| Validation of a CDSA Strategy to Reduce Antibiotic Prescription in Senegal Patient clinical management based on the CDSA strategy - Malaria, Dengue | Not applicable | Completed | Foundation for Innovative New Diagnostics, Switzerland | 470 | 2021-05-03 | 2026-09-16 |
| Mobile Point of Care Diagnostic Testing for Ebola Virus Disease in DRC Differential RPA tests - Ebola Virus Disease, Malaria | Unknown | University of Stirling | 500 | 2021-01-15 | 2020-11-10 | |
| Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal Nafamostat Mesilate - COVID-19 | Phase 3 | Terminated | Institut Pasteur de Dakar | 59 | 2020-08-13 | 2024-06-21 |
| Comparing Several Strategies to Manage Moderate Acute Malnutrition Among Children From 6 to 24 Months Old Azythromycin, Inuline and fructo-oligosaccharides, Albendazole - Moderate Acute Malnutrition | Phase 3 | Completed | Institut Pasteur | 1357 | 2018-01-31 | 2022-05-24 |
| Clinical Efficacy of Trivalent Live-Attenuated Influenza Vaccine (LAIV) Among Children in Senegal SIIL Live Attenuated Influenza Vaccine, Matched placebo - Influenza | Phase 3 | Completed | PATH | 1761 | 2013-05-01 | 2015-06-03 |
Dengue (2) · Growth Disorders (2) · Malaria (2) · COVID-19 (1) · Chikungunya Fever (1) · Cognitive Dysfunction (1) · Diarrhea (1) · Hemorrhagic Fever, Ebola (1) · Influenza, Human (1) · Measles (1) · Neoplasms (1) · Pneumonia (1) · Typhoid Fever (1) · Yellow Fever (1)
Albendazole (1) · Anti-Bacterial Agents (1) · Antiparasitic Agents (1) · Azithromycin (1) · Prebiotics (1) · Probiotics (1) · Vancomycin (1) · fructooligosaccharide (1) · nafamostat (1)
Senegal (9) · Pakistan (2) · Canada (1) · Central African Republic (1) · Democratic Republic of the Congo (1) · Germany (1) · Madagascar (1) · Niger (1)
Aldiouma Diallo, MD (1) · Aliou Barry, MD (1) · Amadou A. Sall, PhD (1) · Asad Ali Syed, MPH (1) · Asad Ali, MPH (1) · Fabien Taieb, MD (1) · Fabien Taieb, MD, PhD (1) · Fatoumata D. Sarr, M.D., MPH (1) · Manfred Weidmann, PhD (1) · Moussa Seydi, MD (1) · Muriel Vray, phD (1) · Yakhya Dieye, PhD (1)